Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami

Autores
Cerasuolo, Joshua O.; Montero Odasso, Manuel; Ibañez, Agustin Mariano; Doocy, Shannon; Lip, Gregory YH; Sposato, Luciano A
Año de publicación
2017
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Atrial fibrillation affects 33.5 million people worldwide and its prevalence is expected to double by 2050 because of the aging population. Atrial fibrillation confers a 5-fold higher risk of ischemic stroke compared to sinus rhythm. We present our view of the role of shared medical decision-making to combat global underutilization of oral anticoagulation for stroke prevention in atrial fibrillation patients. Oral anticoagulation underuse is widespread as it is present within atrial fibrillation patients of all risk strata and in countries across all income levels. Reasons for oral anticoagulation underuse include but are probably not limited to poor risk stratification, over-interpretation of contraindications, and discordance between physician prescription preferences and actual administration. By comparing a catastrophic event to the consequences of atrial fibrillation related strokes, it may help physicians and patients understand the negative outcomes associated with oral anticoagulation under-utilization and the magnitude to which oral anticoagulations neutralize atrial fibrillation burden.
Fil: Cerasuolo, Joshua O.. Western University; Canadá
Fil: Montero Odasso, Manuel. Western University; Canadá
Fil: Ibañez, Agustin Mariano. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Neurociencia Cognitiva. Fundación Favaloro. Instituto de Neurociencia Cognitiva; Argentina. Australian Research Council; Australia. Universidad Adolfo Ibañez; Chile. Universidad Autónoma del Caribe; Colombia
Fil: Doocy, Shannon. Johns Hopkins Bloomberg School Of Public Health; Estados Unidos. University Johns Hopkins; Estados Unidos
Fil: Lip, Gregory YH. University of Birmingham. Institute of Cardiovascular Sciences; Reino Unido
Fil: Sposato, Luciano A. Dementia & Heart Disease Laboratory; Canadá
Materia
Visual Aid
Atrial Fibrillation
Epidemiology
Framing
Oral Anticoagulation
Stroke
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/47951
Acceder
id CONICETDig_168a97160ce95229e0a4b69d0b93800f
oai_identifier_str oai:ri.conicet.gov.ar:11336/47951
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Decision-making interventions to stop the global atrial fibrillation-related stroke tsunamiCerasuolo, Joshua O.Montero Odasso, ManuelIbañez, Agustin MarianoDoocy, ShannonLip, Gregory YHSposato, Luciano AVisual AidAtrial FibrillationEpidemiologyFramingOral AnticoagulationStrokehttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Atrial fibrillation affects 33.5 million people worldwide and its prevalence is expected to double by 2050 because of the aging population. Atrial fibrillation confers a 5-fold higher risk of ischemic stroke compared to sinus rhythm. We present our view of the role of shared medical decision-making to combat global underutilization of oral anticoagulation for stroke prevention in atrial fibrillation patients. Oral anticoagulation underuse is widespread as it is present within atrial fibrillation patients of all risk strata and in countries across all income levels. Reasons for oral anticoagulation underuse include but are probably not limited to poor risk stratification, over-interpretation of contraindications, and discordance between physician prescription preferences and actual administration. By comparing a catastrophic event to the consequences of atrial fibrillation related strokes, it may help physicians and patients understand the negative outcomes associated with oral anticoagulation under-utilization and the magnitude to which oral anticoagulations neutralize atrial fibrillation burden.Fil: Cerasuolo, Joshua O.. Western University; CanadáFil: Montero Odasso, Manuel. Western University; CanadáFil: Ibañez, Agustin Mariano. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Neurociencia Cognitiva. Fundación Favaloro. Instituto de Neurociencia Cognitiva; Argentina. Australian Research Council; Australia. Universidad Adolfo Ibañez; Chile. Universidad Autónoma del Caribe; ColombiaFil: Doocy, Shannon. Johns Hopkins Bloomberg School Of Public Health; Estados Unidos. University Johns Hopkins; Estados UnidosFil: Lip, Gregory YH. University of Birmingham. Institute of Cardiovascular Sciences; Reino UnidoFil: Sposato, Luciano A. Dementia & Heart Disease Laboratory; CanadáWiley Blackwell Publishing, Inc2017-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/47951Cerasuolo, Joshua O.; Montero Odasso, Manuel; Ibañez, Agustin Mariano; Doocy, Shannon; Lip, Gregory YH; et al.; Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami; Wiley Blackwell Publishing, Inc; International Journal Of Stroke; 12; 3; 1-2017; 222-2281747-4930CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/1747493016687579info:eu-repo/semantics/altIdentifier/doi/10.1177/1747493016687579info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:53:00Zoai:ri.conicet.gov.ar:11336/47951instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:53:00.792CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami
title Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami
spellingShingle Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami
Cerasuolo, Joshua O.
Visual Aid
Atrial Fibrillation
Epidemiology
Framing
Oral Anticoagulation
Stroke
title_short Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami
title_full Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami
title_fullStr Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami
title_full_unstemmed Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami
title_sort Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami
dc.creator.none.fl_str_mv Cerasuolo, Joshua O.
Montero Odasso, Manuel
Ibañez, Agustin Mariano
Doocy, Shannon
Lip, Gregory YH
Sposato, Luciano A
author Cerasuolo, Joshua O.
author_facet Cerasuolo, Joshua O.
Montero Odasso, Manuel
Ibañez, Agustin Mariano
Doocy, Shannon
Lip, Gregory YH
Sposato, Luciano A
author_role author
author2 Montero Odasso, Manuel
Ibañez, Agustin Mariano
Doocy, Shannon
Lip, Gregory YH
Sposato, Luciano A
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Visual Aid
Atrial Fibrillation
Epidemiology
Framing
Oral Anticoagulation
Stroke
topic Visual Aid
Atrial Fibrillation
Epidemiology
Framing
Oral Anticoagulation
Stroke
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Atrial fibrillation affects 33.5 million people worldwide and its prevalence is expected to double by 2050 because of the aging population. Atrial fibrillation confers a 5-fold higher risk of ischemic stroke compared to sinus rhythm. We present our view of the role of shared medical decision-making to combat global underutilization of oral anticoagulation for stroke prevention in atrial fibrillation patients. Oral anticoagulation underuse is widespread as it is present within atrial fibrillation patients of all risk strata and in countries across all income levels. Reasons for oral anticoagulation underuse include but are probably not limited to poor risk stratification, over-interpretation of contraindications, and discordance between physician prescription preferences and actual administration. By comparing a catastrophic event to the consequences of atrial fibrillation related strokes, it may help physicians and patients understand the negative outcomes associated with oral anticoagulation under-utilization and the magnitude to which oral anticoagulations neutralize atrial fibrillation burden.
Fil: Cerasuolo, Joshua O.. Western University; Canadá
Fil: Montero Odasso, Manuel. Western University; Canadá
Fil: Ibañez, Agustin Mariano. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Neurociencia Cognitiva. Fundación Favaloro. Instituto de Neurociencia Cognitiva; Argentina. Australian Research Council; Australia. Universidad Adolfo Ibañez; Chile. Universidad Autónoma del Caribe; Colombia
Fil: Doocy, Shannon. Johns Hopkins Bloomberg School Of Public Health; Estados Unidos. University Johns Hopkins; Estados Unidos
Fil: Lip, Gregory YH. University of Birmingham. Institute of Cardiovascular Sciences; Reino Unido
Fil: Sposato, Luciano A. Dementia & Heart Disease Laboratory; Canadá
description Atrial fibrillation affects 33.5 million people worldwide and its prevalence is expected to double by 2050 because of the aging population. Atrial fibrillation confers a 5-fold higher risk of ischemic stroke compared to sinus rhythm. We present our view of the role of shared medical decision-making to combat global underutilization of oral anticoagulation for stroke prevention in atrial fibrillation patients. Oral anticoagulation underuse is widespread as it is present within atrial fibrillation patients of all risk strata and in countries across all income levels. Reasons for oral anticoagulation underuse include but are probably not limited to poor risk stratification, over-interpretation of contraindications, and discordance between physician prescription preferences and actual administration. By comparing a catastrophic event to the consequences of atrial fibrillation related strokes, it may help physicians and patients understand the negative outcomes associated with oral anticoagulation under-utilization and the magnitude to which oral anticoagulations neutralize atrial fibrillation burden.
publishDate 2017
dc.date.none.fl_str_mv 2017-01
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/47951
Cerasuolo, Joshua O.; Montero Odasso, Manuel; Ibañez, Agustin Mariano; Doocy, Shannon; Lip, Gregory YH; et al.; Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami; Wiley Blackwell Publishing, Inc; International Journal Of Stroke; 12; 3; 1-2017; 222-228
1747-4930
CONICET Digital
CONICET
url http://hdl.handle.net/11336/47951
identifier_str_mv Cerasuolo, Joshua O.; Montero Odasso, Manuel; Ibañez, Agustin Mariano; Doocy, Shannon; Lip, Gregory YH; et al.; Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami; Wiley Blackwell Publishing, Inc; International Journal Of Stroke; 12; 3; 1-2017; 222-228
1747-4930
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/1747493016687579
info:eu-repo/semantics/altIdentifier/doi/10.1177/1747493016687579
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613623464329216
score 13.070432

Publicaciones similares